Arcturus Therapeutics is seeking approval from the FDA to go ahead with self-replicating bird flu vaccine trials – The Expose

On Monday, it was announced that Arcturus Therapeutics is actively seeking a green light from the FDA to begin Phase 1 trials for self-replicating “vaccines” against bird flu. Except perhaps for the genetic code contained within them, these are the same injections that were rolled out last month in ..